Palbociclib

Palbociclib is an oral, targeted cancer medicine used to treat certain types of breast cancer. It is a type of drug called a cyclin-dependent kinase (CDK) 4/6 inhibitor, and it works by blocking proteins called CDK 4 and CDK 6 that help cancer cells to grow and spread. Palbociclib is usually used in combination with the hormone therapy drug letrozole to treat advanced breast cancer in women who have already gone through menopause.

Palbociclib, sold under the brand name Ibrance, is a medication used to treat certain types of breast cancer in women [1]. Here's a breakdown of how it works and who it might benefit:

How Palbociclib Works:

• Palbociclib belongs to a class of drugs called cyclin-dependent kinase (CDK) inhibitors.
• Cancer cell growth and division rely on proteins called CDKs. Palbociclib works by blocking the activity of specific CDKs, thereby slowing down the growth and spread of cancer cells [1, 2].

Conditions Treated:

• Palbociclib is primarily used for hormone receptor-positive breast cancer. This means the cancer cells have receptors for hormones like estrogen that can fuel their growth [3].
• It's often used in combination with other medications, such as aromatase inhibitors or Fulvestrant, for advanced or metastatic breast cancer that has spread to other parts of the body [1].
• In some cases, Palbociclib may also be used for early-stage hormone receptor-positive breast cancer in high-risk patients after surgery [4].

Benefits of Palbociclib:

• When combined with other therapies, Palbociclib can help improve progression-free survival (time without the cancer worsening) in patients with advanced breast cancer [1].
• For early-stage breast cancer, it may reduce the risk of cancer recurrence [4].

Important Considerations:

• Palbociclib is not for everyone with breast cancer. It's only suitable for specific types based on hormone receptor status and disease stage.
• It can cause side effects, including low white blood cell count (increased infection risk), fatigue, nausea, and hair loss [1].
• Regular blood tests are needed to monitor blood cell counts while taking Palbociclib.
• Palbociclib can interact with other medications, so it's crucial to inform your doctor about all medications you take before starting treatment [5].